TREATMENT OF METASTATIC MELANOMA AND RENAL-CELL CARCINOMA WITH INTERLEUKIN-2

被引:0
作者
MANSON, LA
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1994年 / 272卷 / 17期
关键词
D O I
10.1001/jama.1994.03520170037027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1327 / 1327
页数:1
相关论文
共 4 条
[1]   ANTITUMOR IMMUNE-RESPONSES OF THE TUMOR-BEARING HOST - THE CASE FOR ANTIBODY-MEDIATED IMMUNOLOGICAL ENHANCEMENT [J].
MANSON, LA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 72 (01) :1-8
[2]   DOES ANTIBODY-DEPENDENT EPITOPE MASKING PERMIT PROGRESSIVE TUMOR-GROWTH IN THE FACE OF CELL-MEDIATED CYTOTOXICITY [J].
MANSON, LA .
IMMUNOLOGY TODAY, 1991, 12 (10) :352-355
[3]   TREATMENT OF 283 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CANCER USING HIGH-DOSE BOLUS INTERLEUKIN-2 [J].
ROSENBERG, SA ;
YANG, JC ;
TOPALIAN, SL ;
SCHWARTZENTRUBER, DJ ;
WEBER, JS ;
PARKINSON, DR ;
SEIPP, CA ;
EINHORN, JH ;
WHITE, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (12) :907-913
[4]   A NEW APPROACH TO THE ADOPTIVE IMMUNOTHERAPY OF CANCER WITH TUMOR-INFILTRATING LYMPHOCYTES [J].
ROSENBERG, SA ;
SPIESS, P ;
LAFRENIERE, R .
SCIENCE, 1986, 233 (4770) :1318-1321